As of 2025-12-18, the EV/EBITDA ratio of Novacyt SA (ALNOV.PA) is -1.35. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ALNOV.PA's latest enterprise value is 17.81 mil EUR. ALNOV.PA's TTM EBITDA according to its financial statements is -13.20 mil EUR. Dividing these 2 quantities gives us the above ALNOV.PA EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 6.9x - 8.6x | 7.6x |
| Forward P/E multiples | 10.4x - 14.3x | 12.1x |
| Fair Price | (1.77) - (1.43) | (1.66) |
| Upside | -509.1% - -432.1% | -484.5% |
| Date | EV/EBITDA |
| 2025-12-12 | -1.34 |
| 2025-12-11 | -1.34 |
| 2025-12-10 | -1.38 |
| 2025-12-09 | -1.43 |
| 2025-12-08 | -1.41 |
| 2025-12-05 | -1.47 |
| 2025-12-04 | -1.32 |
| 2025-12-03 | -1.35 |
| 2025-12-02 | -1.37 |
| 2025-12-01 | -1.37 |
| 2025-11-28 | -1.36 |
| 2025-11-27 | -1.35 |
| 2025-11-26 | -1.34 |
| 2025-11-25 | -1.38 |
| 2025-11-24 | -1.34 |
| 2025-11-21 | -1.33 |
| 2025-11-20 | -1.34 |
| 2025-11-19 | -1.34 |
| 2025-11-18 | -1.36 |
| 2025-11-17 | -1.41 |
| 2025-11-14 | -1.37 |
| 2025-11-13 | -1.39 |
| 2025-11-12 | -1.43 |
| 2025-11-11 | -1.39 |
| 2025-11-10 | -1.42 |
| 2025-11-07 | -1.43 |
| 2025-11-06 | -1.45 |
| 2025-11-05 | -1.45 |
| 2025-11-04 | -1.50 |
| 2025-11-03 | -1.50 |
| 2025-10-31 | -1.45 |
| 2025-10-30 | -1.48 |
| 2025-10-29 | -1.51 |
| 2025-10-28 | -1.50 |
| 2025-10-27 | -1.62 |
| 2025-10-24 | -1.56 |
| 2025-10-23 | -1.58 |
| 2025-10-22 | -1.59 |
| 2025-10-21 | -1.51 |
| 2025-10-20 | -1.51 |
| 2025-10-17 | -1.52 |
| 2025-10-16 | -1.56 |
| 2025-10-15 | -1.56 |
| 2025-10-14 | -1.51 |
| 2025-10-13 | -1.61 |
| 2025-10-10 | -1.61 |
| 2025-10-09 | -1.56 |
| 2025-10-08 | -1.55 |
| 2025-10-07 | -1.60 |
| 2025-10-06 | -1.52 |